Collagen-based bioink for 3D printing applications in biomedical engineering. Enables fabrication of tissue constructs and medical device prototypes with biological compatibility.
Manufactured by
GELITA AG
Eberbach, Germany
GELITA Presents Innovative Excipient Solutions at Compamed 2025 in Düsseldorf GELITA, a global expert in pharmaceutical gelatin and collagen peptides, showcases its latest excipient innovations at Compamed 2025 in Düsseldorf. The company highlights MEDELLAPRO® and VACCIPRO®—two excipients designed to meet the demanding needs of harmaceutical formulations and medical devices. Part of GELITAs Endotoxin Controlled Excipients (ECE) portfolio, MEDELLAPRO® (gelatin) and VACCIPRO® (collagen peptides) are ideal for applications such as vaccine stabilization, tissue engineering, implants, advanced wound care, and 3D bioprinting. Strict endotoxin control ensures product safety and supports regulatory compliance in sensitive medical applications.
© 2026 Suplivia · Home · Browse Products